COIOSDeep risk insights through multi-disciplinary research across the globe
landscape photography of mountains
Item new Peer-reviewed Added

Pneumococci in China are heavily drug resistant as serotype 3 lineages expand

Of 2,841 pneumococcal isolates from 29 Chinese provinces, 98.87% were predicted resistant to at least one antibiotic class.

The study examined Streptococcus pneumoniae in China, where pneumococcal conjugate vaccine (PCV) coverage is low and antibiotic use high. Researchers analysed genomes of 2,841 isolates from 29 provinces, collected 2008 to 2025, against global genomes. One lineage, Global Pneumococcal Sequence Cluster 1, dominated and drove penicillin non-susceptibility, while two serotype 3 lineages expanded. Predicted resistance to at least one class was 98.87%, including 97.18% to macrolide-lincosamide-streptogramin B antibiotics and 97.15% to tetracycline. Estimated serotype coverage was 72.69% for PCV13, 73.39% for PCV15 and 78.35% for PCV20. Resistance was predicted from genes and random forest modelling rather than measured by laboratory testing.

Why it is interesting: China's pneumococcal genomes differ markedly from those in countries with routine PCV programmes. Predicted resistance is near-universal, yet existing vaccines still cover most circulating serotypes.

Source
Journal of Infection, 17 November 2026
Paper
Population dynamics and antimicrobial resistance of S. pneumoniae in China based on Genomic surveillance
Authors
Che J, Dai H, Li J, Chen B, Zhang C, Guo L et al.
DOI
10.1016/j.jinf.2026.106900
Type
Peer-reviewed article
Design
Genomic epidemiology of 2,841 S. pneumoniae isolates, 29 Chinese provinces, 2008–2025, compared against global genomes; serotyping, GPSC assignment, resistance-gene and random-forest AMR prediction, phylogenetic and recombination analysis
Verdict
New finding
Driver
Infection and pandemics

Other drivers in Behavioural science